# Safety Study on AdCD40L Gene Therapy for Bladder Cancer

> **NCT00891748** · PHASE1,PHASE2 · COMPLETED · sponsor: **Uppsala University** · enrollment: 12 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **GENETIC:** AdCD40L

## Key facts

- **NCT ID:** NCT00891748
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2010-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00891748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00891748, "Safety Study on AdCD40L Gene Therapy for Bladder Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00891748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*